| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 88, 2049-2057, Copyright © 1993 by American Heart Association
NL Eigler, B Weinstock, JS Douglas Jr, T Goldenberg, G Hartzler, D Holmes, M Leon, J Margolis, M Nobuyoshi and W O'Neill
BACKGROUND. Percutaneous transluminal coronary angioplasty (PTCA) of
aorto-ostial stenosis has been associated with a lower rate of acute
success, a high risk of vessel closure, and late restenosis. The purpose of
this report is to document a prospective multicenter trial of excimer laser
coronary angioplasty (ELCA) of aorto-ostial stenosis involving the coronary
arteries and saphenous vein grafts. METHODS AND RESULTS. Between December
1989 and May 1992, 206 aorto-ostial ELCA procedures were performed on 209
stenoses in 200 patients. Canadian Cardiovascular Society class III or IV
angina was present in 76%. The distribution of stenosis locations was left
main coronary (LM) in 26 (12%), right coronary (RCA) in 124 (59%), and vein
grafts (VG) in 59 (28%). Adjunctive PTCA was performed in 72%. Procedure
success defined as < or = 50% diameter stenosis without major
complications was achieved in 90% (LM, 92%; RCA, 89%, VG, 90%).
Quantitative angiographic analysis documented an improvement in stenosis
diameter from 0.8 +/- 0.5 mm or 76 +/- 14% at baseline to 2.1 +/- 0.6 mm or
36 +/- 15% at completion (P < .01). The majority of the acute gain in
diameter (1.0 +/- 0.6 mm) resulted from ELCA. A major complication during
hospitalization occurred in 3.9% (death, 0%; Q-wave myocardial infarction,
0.5%; bypass surgery, 3.4%). The only logistic regression univariate and
multivariate predictor of procedure failure was female gender. Six-month
angiographic follow-up, available in 51% of eligible patients, documented
an average lumen diameter of 1.7 +/- 1.0 mm and mean diameter stenosis of
46 +/- 26%. Restenosis (> 50% diameter stenosis) occurred in 39% (LM,
64%; RCA, 35%; VG, 35%). Restenosis was less likely when residual stenosis
was < or = 35% (28% versus 53%, P < .05). Clinical events at
follow-up were death, 2.7%; bypass surgery, 6.5%; myocardial infarction,
2.2%; and repeat angioplasty, 16.2%. Of the remainder, 78% were
asymptomatic, class I or II for anginal symptoms. An adverse event during
follow-up was more than twice as likely in the group with LM (50.0% versus
21.1%, P < .02). CONCLUSIONS. ELCA is acutely effective and safe therapy
in patients with aorto- ostial stenosis. Six-month restenosis,
adverse-event rates were higher and functional status was poorer in the
group with LM stenosis. ELCA may be considered as an alternative to bypass
surgery in carefully selected patients with isolated aorto-ostial stenosis
of the RCA and saphenous vein grafts.
ARTICLES
Excimer laser coronary angioplasty of aorto-ostial stenoses. Results of the excimer laser coronary angioplasty (ELCA) registry in the first 200 patients
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif 90048.
This article has been cited by other articles:
![]() |
W. A. Tan, H. Tamai, S.-J. Park, H.W. T. Plokker, M. Nobuyoshi, T. Suzuki, A. Colombo, C. Macaya, D. R. Holmes Jr, D. J. Cohen, et al. Long-Term Clinical Outcomes After Unprotected Left Main Trunk Percutaneous Revascularization in 279 Patients Circulation, October 2, 2001; 104(14): 1609 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Silvestri, P. Barragan, J. Sainsous, G. Bayet, J.-B. Simeoni, P.-O. Roquebert, G. Macaluso, J.-L. Bouvier, and B. Comet Unprotected left main coronary artery stenting: immediate and medium- term outcomes of 140 elective procedures J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1543 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Luo, T. Nishioka, N. L. Eigler, J. S. Forrester, M. C. Fishbein, H. Berglund, and R. J. Siegel Coronary Artery Restenosis After Balloon Angioplasty in Humans Is Associated With Circumferential Coronary Constriction Arterioscler Thromb Vasc Biol, November 1, 1996; 16(11): 1393 - 1398. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |